Elevated plasma beta-hydroxybutyrate predicts adverse outcomes and disease progression in patients with arrhythmogenic cardiomyopathy

Song, JP; Chen, L; Chen, X; Ren, J; Zhang, NN; Tirasawasdichai, T; Hu, ZL; Hua, W; Hu, YR; Tang, HR; Chen, HSV; Hu, SS

Song, JP; Hu, SS (corresponding author), Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China.; Song, JP; Hu, SS (corresponding author), Chinese Acad Med Sci CAMS & Peking Union Med Coll, Natl Ctr Cardiovasc Dis, Beijing 100037, Peoples R China.; Chen, HSV (corresponding author), Indiana Univ, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.

SCIENCE TRANSLATIONAL MEDICINE, 2020; 12 (530):

Abstract

Sudden death could be the first symptom of patients with arrhythmogenic cardiomyopathy (AC), a disease for which clinical indicators predicting advers......

Full Text Link